Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05431127 · ClinicalTrials.gov registry record · NA
High Dose Inspiratory Muscle Training in LOPD
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05431127 is a NA study that has completed, run by Duke University. The registered enrollment target is 34 participants.
The verdict
NCT05431127, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Study Objectives: 1) assess the safety and feasibility of high-dose inspiratory muscle training (IMT) delivered remotely in Late-onset Pompe Disease (LOPD) and 2) determine its effects on respiratory and patient-reported outcomes.
Interventions
- DEVICE IMT therapy using the Pr02 mobile device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05431127
The ClinicalTrials.gov registry entry for NCT05431127 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IMT therapy using the Pr02 mobile device is the first listed.
NCT05431127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05431127 about?
NCT05431127 is a clinical study titled "High Dose Inspiratory Muscle Training in LOPD". Study Objectives: 1) assess the safety and feasibility of high-dose inspiratory muscle training (IMT) delivered remotely in Late-onset Pompe Disease (LOPD) and 2) determine its effects on respiratory and patient-reported outcomes.
What is the current status of trial NCT05431127?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-07-19. Estimated completion is 2025-01-01.
What interventions are being tested in trial NCT05431127?
The interventions under investigation include: IMT therapy using the Pr02 mobile device (DEVICE).
Who is sponsoring clinical trial NCT05431127?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.